The decrease in adiponectin levels leads to proliferation of hepatic stellate cells and generation of reactive oxygen species in the liver, driving the progression from hepatic steatosis to steatohepatitis and eventually to cirrhosis [88]. This evidence concerns the gene ADIPOQ and fatty liver disease.